NAD+
Nicotinamide adenine dinucleotide
NAD+ (nicotinamide adenine dinucleotide) is one of the most fundamental molecules in your biology — a coenzyme every cell uses for energy production and cellular repair. NAD+ levels fall with age, which is why it sits at the center of the longevity conversation. This guide covers what NAD+ does, how boosting it works, what the research actually shows, the different ways it's used (IV, injectable, oral precursors), dosing references, safety and status.
NAD+ quick facts
| Reported research dosing | 25mg-200mg |
| Route | Either |
| Cycle length | As Long As Needed |
| Frequency | 2-4x Week or Daily |
| Half-life | <1 min (IV); hours as precursor metabolites |
| Forms | Injectable, Nasal |
| Evidence level | Mixed human; strong interest |
Go LOW and SLOW — the discomfort people complain about is dosing too fast, every time.
What NAD+ does & how boosting it works
NAD+ is a coenzyme central to cellular energy (it shuttles electrons in the reactions that make ATP) and it's the required fuel for two important enzyme families: the sirtuins (which regulate metabolism, stress resistance and the communication between the nucleus and mitochondria) and PARPs (which repair DNA). The core longevity idea is simple: NAD+ declines with age, sirtuin and repair activity fall with it, and restoring NAD+ — directly or via precursors — reactivates those pathways, improving mitochondrial function and genomic stability in research models.
What the research shows
In model organisms (fruit flies, nematodes, mice), NAD+ or NAD+-precursor supplementation has increased lifespan and promoted healthier aging, with higher NAD+ activating sirtuins and DNA repair. Human research is progressing — precursors like NMN and NR have shown they can raise NAD+ levels and, in some trials, improve markers like aerobic capacity — but the big 'does it extend human healthspan' question is still being answered. It's a foundational, well-studied molecule with promising but still-maturing human outcome data.
The ways NAD+ is used — IV, injection & oral precursors
There are several routes. Oral precursors (NMN, NR) are the convenient, most-studied consumer route — the body converts them to NAD+. IV NAD+ is offered in wellness clinics, delivering large amounts directly to the bloodstream over a few hours. Subcutaneous NAD+ injection is used as a faster, at-home-style alternative to IV. Direct NAD+ (IV/injection) tends to produce more acute side effects than oral precursors, which is why it's typically done under supervision.
NAD+ dosing (research reference)
Referenced ranges vary widely by route. IV NAD+ is commonly cited around 500–1,500 mg per session, spaced weekly to monthly; clinics also reference 250–1,250 mg/day across multi-day protocols. Subcutaneous use references smaller per-dose amounts reconstituted with bacteriostatic water — the calculator above converts a research amount into syringe units. Oral NMN/NR is dosed in hundreds of mg to ~1 g daily in trials. These summarize existing references for education only; IV or injectable use should be medically supervised.
Safety & side effects
Oral NAD+ precursors are generally very well tolerated in trials. Direct IV/injectable NAD+ more commonly causes acute effects — chest tightness, flushing, headache, nausea — especially if infused quickly, which is why it's administered under medical supervision. As with anything affecting metabolism and DNA-repair pathways, this is educational information, not medical advice.
Related compounds
NAD+ is closely tied to MOTS-c and other metabolic/longevity tools, and oral precursors NMN and NR are the practical way many people target the same pathway without injections.
Legal & regulatory status
NAD+ and its precursors are widely available (NMN/NR are sold as supplements), but injectable/IV NAD+ is not FDA-approved as an anti-aging therapy and is offered off-label in wellness settings. Follow the laws and medical guidance that apply to you.
✅ Clinically validated
- Human trials exist for the precursors — NR and NMN — and are modest: they reliably raise blood NAD+, and translating that into a clinical endpoint has been much harder. Direct IV NAD+ has small studies and no adequately powered randomised trial.
📊 Correlative data
- IV NAD+ is used widely in clinics for fatigue, addiction recovery and post-viral states. The consistent report is that the infusion itself is unpleasant — chest tightness and nausea if run fast — and that the effect is felt immediately by some and not at all by others.
- Subcutaneous and nasal use is common in the research community with a gentler reported profile.
🧪 Theoretical / extrapolated
- NAD+ is the central redox cofactor and the substrate for the sirtuins and PARPs. Tissue NAD+ falls with age, which is the entire premise.
- The unresolved mechanistic question is whether the intact molecule enters cells at all. NAD+ is large and charged; a good deal of evidence suggests it is degraded extracellularly to nicotinamide and re-synthesised inside — which, if true, means direct administration is an expensive route to a cheaper precursor.
These tiers tell you how much human evidence exists — not how well something works. This is the research space, and most of what’s in here is new rather than disproven. Something sitting at “theoretical” usually means nobody has funded the trial, not that the trial was run and failed.
The trap runs the other way too: something can be clinically validated and still do very little for you specifically. A statistically significant result in a study population is not a promise about your body.
- ✅ Clinically validated — human randomised trials or meta-analyses support it. The strongest footing available.
- 📊 Correlative — observational or epidemiological data. Suggestive, and genuinely useful for direction, but it cannot establish cause.
- 🧪 Theoretical / mechanistic — the mechanism is understood and often demonstrated in cells or animals, and the human trial doesn’t exist yet. Unproven is not the same as ineffective. Plenty of what’s standard practice today sat here five years ago.
✗ is a safety flag, not a grade. Where you see it, the concern is harm — not a disappointing trial. A compound tested for one purpose and found not to help there can still be worth studying somewhere else, so a negative result never gets rendered as a cross. It sits alongside the tier, because something can be both well-studied and genuinely risky.
My job is to tell you which one you’re looking at, and let you make the call. Grading something low isn’t me dismissing it — it’s me refusing to oversell it. This is the research space, and being able to reason forward from a mechanism matters as much as waiting for the trial.
NAD+ — safety, predicted from mechanism
Much of this compound class has never been through a human safety trial. Rather than say nothing — or print a generic warning — this is what its known mechanism predicts could go wrong, and what you can do about it. Predictions are labelled as predictions.
What the mechanism predicts
Derived from what this molecule does, not from a trial.
- These are short peptide fragments of organ extracts, and the honest starting point is that the mechanism itself is not established in a way that lets anyone predict harm precisely. The proposal is gene-regulatory — short peptides binding DNA and modulating transcription in a tissue-specific way. If that is what they do, the theoretical concern is influencing transcription in tissue you were not aiming at.
- In practice the doses are tiny, the peptides are short, and they are degraded quickly — which is also the argument that they may do very little at all. Those two possibilities are the same uncertainty viewed from opposite ends, and you should hold both.
What has actually been reported
- Decades of Russian clinical use with a strikingly clean tolerability record — injection-site reactions and little else reported.
- That record comes almost entirely from one research school, is largely unreplicated outside it, and safety data from a group with an interest in the outcome is worth less than the same data from a sceptic. This is not an accusation; it is how evidence weighting works.
How to reduce the risk
Each of these follows from the same mechanism as the prediction.
- Follow the course printed on the label rather than running continuously. These are the one class in the Vault where a duration is STATED rather than inferred, and it is typically 10–20 days repeated a few times a year. Read the box.
- Run one at a time. They are cheap and it is tempting to stack six. If something changes, a stack of six tells you nothing about which one did it — and given the evidence base, attribution is the entire value of your own experiment.
- Decide your endpoint before you start, and make it a marker or a measurable symptom rather than a feeling. With a compound class this under-evidenced, an unfalsifiable endpoint means you will conclude it worked no matter what happened.
- Buy from a source that publishes third-party testing. Where the molecule itself is uncertain, identity and purity are the only variables you can actually control.
What it does to your bloodwork
A fact about the assay, not a guess about the drug.
- Test the ORGAN, not the peptide. A thymic peptide is judged on immune markers, a pineal one on sleep and IGF-1, a vascular one on lipids and inflammatory markers. There is no assay for the compound itself.
Don't run this if
- Pregnancy — not because of a specific finding, but because nobody has studied it and the mechanism claim is transcriptional.
- Active malignancy, on the same reasoning as any tissue-growth signal: unproven, mechanistically arguable, and not worth finding out.
The honest unknown
- Essentially everything a sceptic would want: independent replication, pharmacokinetics, and whether the oral forms survive digestion at all. Unproven is not the same as ineffective — but here it is a large unproven.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this with a pharmacist or doctor.
With food
Absorption is better with a meal, and for anything fat-soluble the fat is doing the work rather than the food generally. This is also the version that is easiest to actually remember, which matters more than it sounds.
Derived from half-life, route and mechanism — not from a dosing trial. Reasoned, and labelled as reasoned.
NAD+ reconstitution calculator
Research reconstitution calculator
Where to get NAD+
Buy NAD+ at AminoWell USA →NAD+ — interference & stacking
Predicted from mechanism, not from an interaction study. There are no trials of these combinations — what follows is what the biology implies, so treat it as a reason to watch something, not as a finding.
What NAD+ moves on your bloodwork
These are the markers this compound is expected to move, and which direction. Knowing that in advance is mostly about NOT panicking: some of these moving is the compound working.
- hs-CRP (High-Sensitivity C-Reactive Protein) — ↓ expected to fall
Where these work, systemic inflammation is the plausible readout.
What to do: hs-CRP is cheap and moves. Baseline and 12 weeks. - HbA1c (Hemoglobin A1c) — ↓ expected to fall
Improved mitochondrial and metabolic function should show here if the effect is real at all.
What to do: The honest use of these markers is as a falsification test: if nothing moves in 12 weeks, the compound is not doing much for you. - Comprehensive Metabolic Panel (CMP) — ◆ worth watching
Liver and kidney function — the standard baseline for anything run long term.
What to do: Twice a year is enough on a stable protocol.
- Which compounds push the same lever, and why the dose adds up faster than people count
- What blunts it — the stacks that waste your money
- What compounds the risk, so a side effect arrives sooner than any one of them suggests
- Coach Cam's read on running it alongside the rest of your protocol
Get the complete breakdown for NAD+ — inside the Academy alongside the full interactive Vault.
Unlock in the Academy — $10/mo →This class is where honest expectation-setting matters most: the markers above are how you find out whether anything happened, and for most of these compounds that question is genuinely open.
Bloodwork to run alongside NAD+
Run these before you start, and again after 8–12 weeks. A baseline you didn’t take is one you can never go back for.
| Marker | What it’s watching for |
|---|---|
| hs-CRP (High-Sensitivity C-Reactive Protein) | Inflammation, which is what most NAD claims route through |
| HbA1c (Hemoglobin A1c) | Metabolic health, the other half |
| Comprehensive Metabolic Panel (CMP) | Liver and kidney baseline |
The Longevity Baseline panel covers these in one order — 13 markers, $219.10 with the discount applied.
Check results you already have → · All 102 markers A–Z
NAD+ — frequently asked questions
What is NAD+?
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme every cell uses for energy production and for fueling repair enzymes (sirtuins and PARPs). Its levels decline with age, which is why it's central to longevity research.
How does boosting NAD+ work?
Restoring NAD+ — directly or via precursors like NMN/NR — reactivates sirtuins and DNA-repair enzymes, improving mitochondrial function and genomic stability in research models.
Does NAD+ actually slow aging?
In animals, NAD+/precursor supplementation increased lifespan and healthspan. In humans, precursors reliably raise NAD+ and improve some markers, but whether it extends human healthspan is still being studied.
What's the difference between IV, injectable, and oral NAD+?
Oral precursors (NMN, NR) are convenient and well-studied; IV NAD+ delivers large amounts directly over hours in a clinic; subcutaneous injection is a faster at-home-style route. Direct NAD+ causes more acute side effects than oral precursors.
How is NAD+ dosed?
IV references commonly cite 500–1,500 mg per session; oral NMN/NR is hundreds of mg to ~1 g daily; subq references smaller amounts reconstituted with bacteriostatic water (see calculator). IV/injectable use should be medically supervised. This is educational, not dosing advice.
Are there side effects to NAD+?
Oral precursors are well tolerated. Direct IV/injectable NAD+ can cause chest tightness, flushing, headache and nausea — especially if infused quickly — which is why it's supervised.
References & further reading
- NAD+ and sirtuins in aging/longevity control (PMC review)
- Targeting NAD+ in metabolic disease — insights (PMC)
- NMN supplementation and aerobic capacity — randomized study (PMC)
Want Coach Cam's exact NAD+ protocol?
Dosing schedules, stacking, cycle timing and my personal notes live inside the Academy — plus the full interactive Vault of 237 compounds & 350 supplements.
Join the Academy — $10/mo →What NAD+ is used for
NAD+ appears under 5 goals in the Vault’s goal router, grouped by the mechanism it works through rather than by how much trial evidence exists. Each link opens that pathway in full, with the alternatives beside it and the bloodwork that tests it.